Co-option of Neutrophil Fates by Tissue Environments.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
25 11 2020
Historique:
received: 10 01 2020
revised: 10 08 2020
accepted: 01 10 2020
pubmed: 26 10 2020
medline: 20 5 2021
entrez: 25 10 2020
Statut: ppublish

Résumé

Classically considered short-lived and purely defensive leukocytes, neutrophils are unique in their fast and moldable response to stimulation. This plastic behavior may underlie variable and even antagonistic functions during inflammation or cancer, yet the full spectrum of neutrophil properties as they enter healthy tissues remains unexplored. Using a new model to track neutrophil fates, we found short but variable lifetimes across multiple tissues. Through analysis of the receptor, transcriptional, and chromatin accessibility landscapes, we identify varying neutrophil states and assign non-canonical functions, including vascular repair and hematopoietic homeostasis. Accordingly, depletion of neutrophils compromised angiogenesis during early age, genotoxic injury, and viral infection, and impaired hematopoietic recovery after irradiation. Neutrophils acquired these properties in target tissues, a process that, in the lungs, occurred in CXCL12-rich areas and relied on CXCR4. Our results reveal that tissues co-opt neutrophils en route for elimination to induce programs that support their physiological demands.

Identifiants

pubmed: 33098771
pii: S0092-8674(20)31309-X
doi: 10.1016/j.cell.2020.10.003
pii:
doi:

Substances chimiques

Chromatin 0
NR4A1 protein, human 0
Nuclear Receptor Subfamily 4, Group A, Member 1 0
Receptors, CXCR4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1282-1297.e18

Subventions

Organisme : Versus Arthritis
ID : 20892
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Iván Ballesteros (I)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain. Electronic address: iballesteros@cnic.es.

Andrea Rubio-Ponce (A)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain; Bioinformatics Unit, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

Marco Genua (M)

Vita-Salute San Raffaele University and San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.

Eleonora Lusito (E)

Vita-Salute San Raffaele University and San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.

Immanuel Kwok (I)

Singapore Immunology Nework (SIgN), A(∗)STAR, Biopolis, Singapore 138648, Singapore.

Gabriel Fernández-Calvo (G)

Department of Mathematics & MOLAB-Mathematical Oncology Laboratory, University of Castilla-La Mancha, Ciudad Real 13001, Spain.

Tariq E Khoyratty (TE)

Kennedy Institute of Rheumatology, University of Oxford, OX3 7FY, UK.

Erinke van Grinsven (E)

Kennedy Institute of Rheumatology, University of Oxford, OX3 7FY, UK.

Sara González-Hernández (S)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

José Ángel Nicolás-Ávila (JÁ)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

Tommaso Vicanolo (T)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

Antonio Maccataio (A)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

Alberto Benguría (A)

Genomic Unit, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

Jackson LiangYao Li (JL)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain; Singapore Immunology Nework (SIgN), A(∗)STAR, Biopolis, Singapore 138648, Singapore.

José M Adrover (JM)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

Alejandra Aroca-Crevillen (A)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

Juan A Quintana (JA)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

Sandra Martín-Salamanca (S)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

Francisco Mayo (F)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

Stefanie Ascher (S)

Institute for Pharmacy & Biochemistry, Johannes Gutenberg University of Mainz, Johann-Joachim-Becher-Weg 30, Mainz 55128, Germany.

Giulia Barbiera (G)

Vita-Salute San Raffaele University and San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.

Oliver Soehnlein (O)

Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximillians-Universitat, Munich 80802, Germany.

Matthias Gunzer (M)

Institute for Experimental Immunology and Imaging, University Hospital, University Duisburg-Essen, Essen 445141, Germany.

Florent Ginhoux (F)

Singapore Immunology Nework (SIgN), A(∗)STAR, Biopolis, Singapore 138648, Singapore.

Fátima Sánchez-Cabo (F)

Bioinformatics Unit, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

Estanislao Nistal-Villán (E)

Microbiology Section, Department Pharmacological and Health Sciences, Facultad de Farmacia, Universidad CEU San Pablo, Madrid 28668, Spain.

Christian Schulz (C)

Medizinische Klinik und Poliklinik I, LMU Klinikum, Ludwig-Maximilians-Universität, Munich 80336, Germany; DZHK (German Centre for Cardiovascular Research), Munich 80802, Germany.

Ana Dopazo (A)

Genomic Unit, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain.

Christoph Reinhardt (C)

Center for Thrombosis and Hemostasis Mainz (CTH), University Medical Center Mainz, Johannes Gutenberg University of Mainz, Mainz 55131, Germany.

Irina A Udalova (IA)

Kennedy Institute of Rheumatology, University of Oxford, OX3 7FY, UK.

Lai Guan Ng (LG)

Singapore Immunology Nework (SIgN), A(∗)STAR, Biopolis, Singapore 138648, Singapore.

Renato Ostuni (R)

Vita-Salute San Raffaele University and San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan 20132, Italy.

Andrés Hidalgo (A)

Area of Cell & Developmental Biology, Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid 28029, Spain; Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximillians-Universitat, Munich 80802, Germany. Electronic address: ahidalgo@cnic.es.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH